Webdisclosure.com

Search

H&R GMBH & CO. KGAA (FRA:DE000A2E) H&R GmbH & Co. KGaA: Company publishes earnings- and revenue trends for Q3-2019

Directive transparence : information réglementée

15/11/2019 14:33

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): 9 Month figures/Quarter Results
H&R GmbH & Co. KGaA: Company publishes earnings- and revenue trends for Q3-2019
15.11.2019 / 14:33
The issuer is solely responsible for the content of this announcement.


Press Release

H&R GmbH & Co. KGaA GmbH & Co. KGaA publishes earnings- and revenue trends for Q3-2019

- Difficult market conditions impact sales and earnings

- EBITDA reaches EUR 44.8 million

Salzbergen, November 15, 2019. H&R GmbH & Co. KGaA (abbrev.: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary revenue and earnings figures for the first nine months of 2019: Between January and September 2019, the company achieved an EBITDA figure (EBITDA - Consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment) of EUR 44.8 million (same period of the previous year: EUR 59.7 million). This figure includes one-off personnel restructuring costs of around EUR 4.0 million for the Coburg site. Net profit to shareholders was EUR 4.1 million, down on the previous year (first nine months 2018: EUR 20.2 million). In total, H&R KGaA thus generated earnings per share of EUR 0.11 in a persistently poor market situation for key customer industries. At EUR 824.7 million, sales were below the prior-year figure (first nine months of 2018: EUR 833.7 million).

Overview of the main key figures:

in EUR Million First 9 months of 2019 First 9 months of 2018 Absolute diff.
Sales revenues 824.7 833.7 -9.0
ChemPharm REFINING 513.8 522.6 -8.8
ChemPharm SALES 285.4 275.7 9.7
PLASTICS 32.9 43.0 -10.1
Reconciliation -7.4 -7.7 0.3
       
Operating income (EBITDA) 44.8 59.7 -14.9
ChemPharm REFINING 27.0 36.6 -9.6
ChemPharm SALES 22.5 23.2 -0.7
PLASTICS -5.4 2.9 -8.3
Reconciliation 0.7 -2.9 3.6
       
EBIT 11.4 34.4 -23.0
EBT 5.6 28.6 -23.0
Net profit/loss to shareholders 4.1 20.2 -16.1
Consolidated earnings per share (EUR) 0.11 0.55 -0.44
Operating cash flow 71.1 9.3 61.8
Free cash flow 24.6 -34.7 59.3
  Q3-2019 Q3-2018 Absolute diff.
Sales revenues 274.7 283.3 -8.6
ChemPharm REFINING 168.4 175.2 -6.8
ChemPharm SALES 97.4 98.6 -1.2
PLASTICS 10.9 12.5 -1.6
Reconciliation -2.1 -3.0 0.9
       
Operating income (EBITDA) 5.1 18.5 -13.4
ChemPharm REFINING 4.1 11.4 -7.3
ChemPharm SALES 7.3 8.3 -1.0
PLASTICS -5.0 0.2 -5.2
Reconciliation -1.3 -1.4 0.1
       
EBIT -6.5 10.1 -16.6
EBT -8.4 7.7 -16.1
Net profit/loss to shareholders -6.0 5.3 -11.3
Consolidated earnings per share (EUR) -0.16 0.14 -0.30
Operating cash flow 20.0 24.9 -4.9
Free cash flow 3.7 5.8 -2.1
  9/30/2019 12/31/2018 Absolute diff.
Balance sheet total 799.2 730.4 68.8
Group equity 359.5 357.4 2.1
Equity Ratio (%) 45.0 48.9 -3.9
 

H&R currently expects to achieve an operating income of around EUR 55.0 million for FY 2019.

For further statements on the trends in business performance and earnings, the company refers to the quarterly report for the third quarter of 2019 published today, which is available for download at www.hur.com in the "Investor Relations" section.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: ties.kaiser@hur.com ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.



15.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: investor.relations@hur.com
Internet: www.hur.com
ISIN: DE000A2E4T77
WKN: A2E4T7
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 914453

 
End of News DGAP News Service

914453  15.11.2019 

fncls.ssp?fn=show_t_gif&application_id=914453&application_name=news&site_id=symex